Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P715 The prevalence of chronic musculoskeletal pain in patients with ulcerative colitis in comparison to control subjects: A cross-sectional study

ECCO'20 Vienna

Year: 2020
Authors:

N. Pettersson1, F. Kragsbjerg1, A. Hamrin2, H. Forsblad-D′elia3, P. Karling1

1Department of Public Health and Clinical Medicine- Umeå University, Medicine, Umeå, Sweden, 2Region Västernorrland, Medicine, Sundsvall, Sweden, 3Department of Public Health and Clinical medicine- Umeå University, Reumatology and Medicine, Umeå, Sweden

P716 Clinical significance of residual non-rectal inflammation in ulcerative colitis patients with clinical remission

ECCO'20 Vienna

Year: 2020
Authors:

J. Shin, G. Seong, J.H. Song, S.M. Kong, T.J. Kim, E.R. Kim, S.N. Hong, D.K. Chang, Y.H. Kim

Samsung Medical Center, Internal Medicine Gastroenterology and Hepatology, Seoul, Republic of Korea

P717 Ustekinumab in Crohn’s disease: Real-world outcomes from the Sicilian Network for inflammatory bowel diseases (SN-IBD):–Preliminary results

ECCO'20 Vienna

Year: 2020
Authors:

A. Viola1, G. Fiocco1, A. Alibrandi2, F.S. Macaluso3, M. Cappello4, A.C. Privitera5, G. Magrì6, S. Garufi7, A. Centritto1, M. Ventimiglia3, E. Giuffrida4, C. Ferracane6, G. Costantino1, S. Renna3, A. Orlando3, W. Fries1

1Inflammatory Bowel Disease Unit, Department of Clinical and Experimental Medicine, University of Messina, A.O.U. Policlinico ‘G. Martino’, Messina, Italy, 2Department of Economics, Unit of Statistical and Mathematical Sciences, University of Messina, Italy, 3A.O.O.R. ‘Villa Sofia-Cervello’, Inflammatory Bowel Disease Unit, Palermo, Italy, 4Gastroenterology and Hepatology Unit, A.O.U. Policlinico ‘G. Giaccone’,, University of Palermo, , Palermo, Italy, 5A.O Cannizzaro, Inflammatory Bowel Disease Unit, Catania, Italy, 6A.O. ‘Santa Marta e S. Venera’, Gastroenterology Unit, Acireale, Italy, 7A.O.O.R. ‘S. Elia- M. Raimondi’, Gastroenterology Unit, Caltanissetta, Italy

P718 Combination therapy of adalimumab with an immunomodulator is not more effective than adalimumab monotherapy in children with Crohn’s disease

ECCO'20 Vienna

Year: 2020
Authors:

M. Matar1, R. Shamir1, D. Turner2, E. Broide3, B. Weiss4, O. Ledder2, A. Guz-Mark1, F. Rinawi1, S. Cohen5, C. Topf Olivestone6, R. Shaul7, S. Ben-Horin8, A. Assa1

1The Schneider Children’s Hospital, Petach-Tikva, Israel, The institute of Gastroenterology- Nutrition and Liver diseases, Petach Tikva, Israel, 2Shaare Zedek Medical Center- The Hebrew University, Jerusalem, Israel, The Juliet Keidan institute of Pediatric Gastroenterology, Jerusalem, Israel, 3Shamir Assaf Harofeh Medical Center, Pediatric Gastroenterology Unit, Zerifin, Israel, 4Edmond and Lily Safra Children’s Hospital, Pediatric Gastroenterology Unit, Ranat Gan, Israel, 5Dana-Dwek Children’s Hospital, Tel Aviv Sourasky Medical Center, Pediatric Gastroenterology Unit, Tel Aviv, Israel, 6Kaplan Medical Center, Pediatric Gastroenterology Unit, Rehovot, Israel, 7Rambam Medical Center, Pediatric Gastroenterology Unit, Haifa, Israel, 8Sheba Medical Center, Department of Gastroenterology, Ramat Gan, Israel

P719 Effectiveness and safety of ustekinumab induction therapy in ulcerative colitis: A GETAID real-world cohort study

ECCO'20 Vienna

Year: 2020
Authors:

A. Amiot1, A. Vered2, J. Filippi3, G. Cadiot4, D. Laharie5, S. Melanie6, R. Altwegg7, Y. Bouhnik8, L. Peyrin-biroulet9, C. Gilletta10, X. Roblin11, G. Pineton de chambrun7, L. Vuitton12, A. Bourrier13, S. Nancey14, J.M. Gornet15, S. Nahon16, G. Bouguen17, S. Viennot18, P. Benjamin19, M. Fumery20, GETAID

1Gastroenterology, Henri Mondor Hospital, Creteil, France, 2Gastroenterology, Cochin Hospital, Paris, France, 3Gastroenterology, Nice University Hospital, Nice, France, 4Gastroenterology, Reims University Hospital, Reims, France, 5Gastroenterology, Bordeaux University Hospital, Bordeaux, France, 6Gastroenterology, Marseille University Hospital, Marseille, France, 7Gastroenterology, Montpellier University Hospital, Montpellier, France, 8Gastroenterology, Beaujon Hospital, Clichy, France, 9Gastroenterology, Nancy University Hospital, Nancy, France, 10Gastroenterology, Toulouse University Hospital, Toulouse, France, 11Gastroenterology, St Etienne, St Etienne, France, 12Gastroenterology, Besancon University Hospital, Besancon, France, 13Gastroenterology, St Antoine Hospital, Paris, France, 14Gastroenterology, Lyon University Hospital, Lyon, France, 15Gastroenterology, St Louis Hospital, Paris, France, 16Gastroenterology, Montfermeil Hospital, Montfermeil, France, 17Gastroenterology, Rennes University Hospital, Rennes, France, 18Gastroenterology, Caen University Hospital, Caen, France, 19Gastroenterology, Lille, Lille, France, 20Department of Gastroenterology and Hepatology, Amiens University Hospital, Amiens Cedex 1, France

P720 Recurrent rectovaginal fistula in patients with Crohn’s disease: How can we improve the success rate of graciloplasty? A bi-centric European study in 30 patients

ECCO'20 Vienna

Year: 2020
Authors:

A. Frontali1, M. Rottoli2, A. Chierici1, G. Poggioli2, Y. Panis3

1Beaujon Hospital, Colorectal Surgery, Clichy, France, 2Ospedale Policlinico di Sant’Orsola-Malpighi, Digestive Surgery, Bologna, Italy, 3APHP Beaujon, Department of Colorectal Surgery, Clichy, France

P721 Early vedolizumab trough levels are associated with induction therapy outcome

ECCO'20 Vienna

Year: 2020
Authors:

J. O’Connell1, R. Corcoran1, R. Argue1, P. McDonagh1, M.S. Ismail2, G. Cullen3, G. Doherty3, K. Hartery1, M. Healy4, M. McCormack4, F. MacCarthy1, S. McKiernan1, A. O’Connor2, B. Ryan2, D. McNamara2, D. Kevans1

1Department of Gastroenterology, St James’s Hospital, Dublin, Ireland, 2Gastroenterology, Tallaght University Hospital, Dublin, Ireland, 3Gastroenterology, St Vincent’s University Hospital, Dublin, Ireland, 4Department of Biochemistry, St James’s Hospital, Dublin, Ireland

P722 Upadacitinib was not associated with anaemia in patients with moderately to severely active ulcerative colitis: Results from the U-ACHIEVE study

ECCO'20 Vienna

Year: 2020
Authors:

G. D’Haens1, X. Hebuterne2, P.D.R. Higgins3, E.V. Loftus- Jr.4, W. Zhou5, A.P. Lacerda5, W. Xie6, J. Liu6, S. Danese7

1Department of Gastroenterology and Hepatology- C2-112- Inflammatory Bowel Disease Center, Academic Medical Center AMC University of Amsterdam, Amsterdam, The Netherlands, 2Université de Nice-Sophia Antipolis- Hôpital de l’Archet, Faculté de Médecine, Nice, France, 3Department of Medicine- Division of Gastroenterology, University of Michigan, Ann Arbor, USA, 4Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, USA, 5AbbVie Inc., Global Pharmaceutical Research and Development, North Chicago, USA, 6AbbVie Inc., Data and Statistical Sciences, North Chicago, USA, 7Humanitas Clinico Research Centre, IBD Centre, Milan, Italy

P723 Therapeutic thresholds for golimumab serum concentrations during induction and maintenance: Results from the GO-LEVEL study

ECCO'20 Vienna

Year: 2020
Authors:

M. Samaan1, G. Cunningham1, G. Tamilarasan1, K. Rawstron2, K. Hawash2, L. Beltran2, S. Ray1, J. Mawdsley1, S. Anderson1, J. Sanderson1, Z. Arkir2, P. Irving1

1Guy’s & St Thomas’ NHS Foundation Trust, Gastroenterology, London, UK, 2Guy’s & St Thomas’ NHS Foundation Trust, Viapath Laboratories, London, UK

P724 Delaying an infliximab infusion by more than 3 days is associated with a significant reduction in trough levels

ECCO'20 Vienna

Year: 2020
Authors:

B. Ungar1,2, Z. Ben-Shatach1,2, T. Ziv-Baran2,3, E. Fudim1,2, M. Yavzori1,2, O. Picard1,2, L. Selinger1,2, B. Weiss2,4, U. Kopylov1,2, R. Eliakim1,2, S. Ben-Horin1,2

1Department of Gastroenterology, Sheba Medical Center- Tel Hashomer, Ramat gan, Israel, 2Tel-Aviv University, Sackler School of Medicine, Tel Aviv, Israel, 3Department of Epidemiology and Preventive Medicine, School of Public Health, Tel Aviv, Israel, 4Department of Pediatric Gastroenterology, Sheba Medical Center- Tel Hashomer, Ramat gan, Israel

P725 Trends in biologic use prior to resective surgery for inflammatory bowel disease: A Canadian population-based study

ECCO'20 Vienna

Year: 2020
Authors:

D. Chopra1, E. Kennedy2, A.V. Weizman1, A. Tennakoon3, L.E. Targownik1

1Gastroenterology, Mount Sinai Hospital, Toronto, Canada, 2General Surgery, Mount Sinai Hospital, Toronto, Canada, 3Centre for Global and Public Health, University of Manitoba, Winnepeg, Canada

P726 Effectiveness of vedolizumab therapy in a real-world setting in Germany: First results of the VEDOibd study comparing vedolizumab to the use of other biologics

ECCO'20 Vienna

Year: 2020
Authors:

B. Bokemeyer1, S. Plachta-Danielzik2, C. Sobotzki3, W. Mohl4, M. Hoffstadt5, T. Krause6, R. Atreya7, M. von der Ohe8, U. Graefe9, L. Trentmann10, M. Eisold11, A. Linde9, S. Franzenburg13, M. Moser13, P. Hartmann14, S. Schreiber15, German IBD Study Group (GISG)

1Gastroenterologische Gemeinschaftspraxis Minden and University Hospital Schleswig-Holstein, Campus Kiel, Clinic for Internal Medicine I, Gastroenterology Practice, Minden, Germany, 2Competence-net IBD Germany, Study Department, Kiel, Germany, 3Competence-net IBD, Statistic Department, Kiel, Germany, 4Gastroenterology Practice Saarbrücken, Gastroenterology, Saarbrücken, Germany, 5Gastroenterology Practice Iserlohn, Gastroenterology, Iserlohn, Germany, 6Gastroentrology Practice Kassel, Gastroenterology, Kassel, Germany, 7University Hospital Erlangen, Gastroenterology Department, Erlangen, Germany, 8Gastroenterology Practice Herne, Gastroenterology, Herne, Germany, 9Gastroenterology Practice Berlin, Gastroenterology, Berlin, Germany, 10Gastroenterogy Practice Bremen, Gastroenterology, Bremen, Germany, 11Gastroenterology Practice Mössingen, Gastroenterology, Mössingen, Germany, 13Competence-net IBD, Study Department, Kiel, Germany, 14Gastroenterology Practice Minden, Study Nurse, Minden, Germany, 15University Hospital Schleswig-Holstein- Campus Kiel- Clinic for Internal Medicine I, Gastroenterology Department, Kiel, Germany

P727 Small bowel capsule endoscopy impact on therapeutic decisions in established Crohn’s disease: Analysis of a real-world data

ECCO'20 Vienna

Year: 2020
Authors:

E.J. Gómez, R.A. Gonzalez, L. Pereyra, J.M. Mella, G.N. Panigadi, C. Fischer, M. Roel, D.G. Cimmino, S. Pedreira, L.A. Boerr

Hospital Alemán, Department of Gastroenterology, Caba, Buenos Aires, Argentina

P728 Comparative assessment of faecal microbiota transplantation and current therapies as induction treatment for active refractory ulcerative colitis: A systematic review and network meta-analysis

ECCO'20 Vienna

Year: 2020
Authors:

K. Malandris1, P. Paschos1, A. Koukoufiki1, A. Katsoula1, A. Manolopoulos1, A. Tsapas1,2, E. Bekiari1

1Aristotle University of Thessaloniki, Clinical research and Evidence-Based Medicine Unit, Thessaloniki, Greece, 2University of Oxford, Harris Manchester College, Oxford, UK

P729 The SAPPHIRE registry: Safety of immunosuppression in a prospective cohort of inflammatory bowel disease patients with a HIstoRy of CancEr

ECCO'20 Vienna

Year: 2020
Authors:

J. Axelrad1, J.F. Colombel2, E. Scherl3, D. Lukin3, S. Chang1, L. Chen1, J. Kwah4, A. Swaminath5, K. Sultan5, G. Lawlor6, C. Villagra2, J. Galanko7, V. Sharpless7, S. Itzkowitz2, New York Crohn’s and Colitis Organization (NYCCO)

1Gastroenterology, New York University School of Medicine, New York, USA, 2Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, USA, 3Gastroenterology, Weill Medical College of Cornell University, New York, USA, 4Gastroenterology, Albert Einstein College of Medicine, New York, USA, 5Gastroenterology, Hofstra Northwell School of Medicine, New York, USA, 6Columbia University Medical Center, Digestive and Liver Diseases, New York, USA, 7Gastroenterology, University of North Carolina School of Medicine, Chapel Hill, USA

P730 Effectiveness and safety of endoscopic balloon dilation of colorectal strictures in Crohn’s disease

ECCO'20 Vienna

Year: 2020
Authors:

M. TILMANT1, M. serrero2, F. Poullenot3, G. Bouguen4, B. Pariente5, R. Altwegg6, P. Basile7, J. Filippi8, P. Vanelslander9, A. Buisson10, L. Vuitton11, A. Desjeux2, D. Laharie3, E. Le Balch4, M. Nachury5, L. Boivineau6, G. Savoye7, X. Hebuterne8, L. Poincloux10, A. Lamrani12, M. Fumery1

1CHU Amiens Sud, Service d’hepato-gastroentérologie, Amiens, France, 2APHM Hopital Nord, Hepato-gastroenterologie, Marseille, France, 3Hopital Haut Leveque, Hépato-gastroentérologie, Bordeaux, France, 4CHU Pontchaillou, Gastroenterologie, Rennes, France, 5Hopital Claude huriez, Gastroentérologie, Lille, France, 6Hôpital Saint Eloi, Gastroentérologie, Montpellier, France, 7Hopital Charles Nicolle, Gastroentérologie, Rouen, France, 8Hopital de l’Archet, Gastroentérologie, Nice, France, 9Policlinique Saint Claude, Gastroentérologie, Saint Quentin, France, 10Hopital universitaire, Gastroentérologie, Clermont Ferrand, France, 11Hopital universitaire, Gastroentérologie, Besançon, France, 12CHU Amiens Sud, Statistique, Amiens, France

P731 Biologics use in elderly patients with IBD: Experience in a UK secondary care setting

ECCO'20 Vienna

Year: 2020
Authors:

C. Alexakis, J. Robinson, R. Yeates, N. Ho-Yen, S. Mathew, M. Gallagher, C. Banks, K. Alexandropoulou

Royal Surrey NHS Foundation Trust, Department of Gastroenterology, Guildford, UK

P732 The clinical efficacy and safety of indigo naturalis in induction & maintenance therapy for moderate-to-severe ulcerative colitis: A single-centre prospective uncontrolled open-label study

ECCO'20 Vienna

Year: 2020
Authors:

Y. Matsuno1, A. Hirano1, T. Torisu1, Y. Fuyuno1, Y. Okamoto1, F. Shin1, M. Tomohiko1, J. Umeno1, Y. Hirakawa1,2, M. Esaki3, T. Kitazono1

1Kyushu University, Department of Medicine and Clinical Science, Fukuoka, Japan, 2Kyushu University, Department of Epidemiology and Public Health, Fukuoka, Japan, 3Saga University Hospital, Department of Endoscopic Diagnostics and Therapeutics, Saga, Japan

P733 The influence of concomitant familial Mediterranean fewer on Crohn’s disease course: Data from an FMF endemic area

ECCO'20 Vienna

Year: 2020
Authors:

I. Yuksel1,2, S. Kilincalp3, Y. Coskun3, H. Akinci3, M. Hamamci3

1Department of Gastroenterology, Yildirim Beyazit University Ankara, Turkey, 2Deparment of Gastroenterology, Ankara Sehir Hospital, Ankara, Turkey, 3Department of Gastroenterology, Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey

P734 Should we have a higher threshold for anti-TNF serum levels in Crohn’s disease patients with perianal disease?

ECCO'20 Vienna

Year: 2020
Authors:

C. Arieira1,2,3, F. Dias de Castro1,2,3, T. Cúrdia Gonçalves1,2,3, M.J. Moreira1,2,3, J. Cotter1,2,3

1Hospital Senhora da Oliveira, Gastroenterology, Guimarães, Portugal, 2Life and Health Sciences Research Institute, School of Medicine, University of Minho, Braga/Guimarães, Portugal, 3ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal